- Home
- GRRR vs OVID Comparison
GRRR vs OVID Comparison
Compare GRRR & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- OVID
- Stock Information
- Founded
- GRRR 2001
- OVID 2014
- Country
- GRRR United Kingdom
- OVID United States
- Employees
- GRRR N/A
- OVID N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- GRRR Technology
- OVID Health Care
- Exchange
- GRRR Nasdaq
- OVID Nasdaq
- Market Cap
- GRRR 85.6M
- OVID 73.1M
- IPO Year
- GRRR N/A
- OVID 2017
- Fundamental
- Price
- GRRR $13.37
- OVID $1.00
- Analyst Decision
- GRRR Buy
- OVID Strong Buy
- Analyst Count
- GRRR 1
- OVID 5
- Target Price
- GRRR $13.00
- OVID $4.04
- AVG Volume (30 Days)
- GRRR 2.7M
- OVID 296.7K
- Earning Date
- GRRR 01-03-2025
- OVID 11-12-2024
- Dividend Yield
- GRRR N/A
- OVID N/A
- EPS Growth
- GRRR N/A
- OVID N/A
- EPS
- GRRR 2.28
- OVID N/A
- Revenue
- GRRR $78,940,347.00
- OVID $631,695.00
- Revenue This Year
- GRRR $12.29
- OVID $71.38
- Revenue Next Year
- GRRR $21.40
- OVID $5,144.81
- P/E Ratio
- GRRR $5.87
- OVID N/A
- Revenue Growth
- GRRR 424.97
- OVID 113.21
- 52 Week Low
- GRRR $2.09
- OVID $0.68
- 52 Week High
- GRRR $14.37
- OVID $4.10
- Technical
- Relative Strength Index (RSI)
- GRRR 87.34
- OVID 39.12
- Support Level
- GRRR $5.75
- OVID $0.99
- Resistance Level
- GRRR $8.24
- OVID $1.09
- Average True Range (ATR)
- GRRR 1.32
- OVID 0.08
- MACD
- GRRR 0.60
- OVID -0.01
- Stochastic Oscillator
- GRRR 88.40
- OVID 2.26
About GRRR Gorilla Technology Group Inc. Ordinary shares
Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.